To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SNHG3_TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
494 supporting clones for gene SNHG3_ back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
X12654   .a 1 to 2424 1 to 2424 exact tiling clone,   2424/2424
(100 %)
1 diff
(100.0 %id)
BX331596 Neuroblastoma Cot 10-normalized .a 98 to 969 1 to 877       877/877
(100 %)
12 diff
(98.7 %id)
NM_001269.3   .a 98 to 2536 1 to 2439   RefSeq,   2439/2439
(100 %)
0 diff
(100 %id)
BX416625 neuroblastoma .a 101 to 1120 1 to 1016       1016/1094
(92 %)
7 diff
(99.4 %id)
AI879061 brain, frontal lobe .a 111 to 719 1 to 611     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 611/611
(100 %)
9 diff
(98.6 %id)
CA487880   .a 112 to 714 1 to 612       612/757
(80 %)
21 diff
(97.3 %id)
BX420738 brain, fetal brain .a 114 to 1181 1 to 1069       1069/1130
(94 %)
15 diff
(98.7 %id)
BI334273 cervical carcinoma cell line, cervix .a 118 to 882 10 to 772       765/772
(99 %)
16 diff
(98.0 %id)
BM907109 brain, hippocampus .a 119 to 841 1 to 722       722/1146
(63 %)
13 diff
(98.9 %id)
BP284522 bone marrow .a 119 to 705 1 to 588       588/588
(100 %)
4 diff
(99.4 %id)
BP247684 Kidney .a 120 to 702 1 to 583       583/583
(100 %)
5 diff
(99.2 %id)
BM839854 myeloma .a 120 to 652 1 to 533       533/533
(100 %)
0 diff
(100 %id)
BP365400 lung .a 120 to 712 1 to 593       593/593
(100 %)
1 diff
(99.9 %id)
BM555115 duodenal adenocarcinoma, cell line, small intestine .a 122 to 1133 1 to 1021       1021/1034
(98 %)
28 diff
(97.3 %id)
AL529479 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 123 to 1120 1 to 990       992/1040
(95 %)
13 diff
(98.8 %id)
CN366101 embryonic stem cells, cell lines H1, H7, andH9 .a 124 to 669 20 to 565       546/565
(96 %)
6 diff
(99.0 %id)
BG684677 B-cells, primary B-cells from tonsils (cell line) .a 126 to 838 1 to 718       718/837
(85 %)
16 diff
(98.1 %id)
BG684817 B-cells, primary B-cells from tonsils (cell line) .a 126 to 663 1 to 541       541/545
(99 %)
5 diff
(99.1 %id)
BG685110 B-cells, primary B-cells from tonsils (cell line) .a 126 to 950 1 to 820       822/821
(100 %)
19 diff
(97.7 %id)
BG685749 B-cells, primary B-cells from tonsils (cell line) .a 126 to 803 1 to 679       679/681
(99 %)
6 diff
(99.2 %id)
BG756133 B-cells, primary B-cells from tonsils (cell line) .a 126 to 791 1 to 665       665/665
(100 %)
3 diff
(99.6 %id)
BG754669 B-cells, primary B-cells from tonsils (cell line) .a 126 to 854 1 to 728       728/728
(100 %)
6 diff
(99.2 %id)
BX490272   .a 132 to 662 1 to 531       531/531
(100 %)
1 diff
(99.9 %id)
BI093459 cervix .a 136 to 1006 1 to 872       872/903
(96 %)
26 diff
(97.2 %id)
BU170765 eye, retinoblastoma .a 138 to 624 1 to 492       492/858
(57 %)
17 diff
(98.1 %id)
BM802635 embryonal carcinoma, cell line, testis .a 141 to 694 1 to 554       554/1191
(46 %)
20 diff
(98.4 %id)
CR997035 T-Lymphocytes .a 144 to 877 1 to 734       734/734
(100 %)
1 diff
(99.9 %id)
BQ648117 hepatocellular carcinoma, cell line, Liver .a 148 to 826 11 to 692       682/987
(69 %)
19 diff
(98.1 %id)
BG764735 melanotic melanoma, high MDR (cell line), skin .a 149 to 883 1 to 734       734/734
(100 %)
1 diff
(99.9 %id)
BQ653506 hepatocellular carcinoma, cell line, Liver .a 149 to 1016 1 to 873       873/932
(93 %)
31 diff
(96.7 %id)
BP249067 Kidney .a 152 to 732 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BG257155 embryonal carcinoma, cell line, testis .a 157 to 843 1 to 687       687/1023
(67 %)
13 diff
(98.8 %id)
CN366105 embryonic stem cells, DMSO-treated H9 cellline .a 160 to 481 1 to 322       322/322
(100 %)
7 diff
(97.9 %id)
CX755873 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 160 to 871 1 to 712     Submitted on the opposite strand 712/712
(100 %)
1 diff
(99.9 %id)
BC001589 Lymph, Burkitt lymphoma .a 161 to 2424 1 to 2264   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2264/2264
(100 %)
1 diff
(100.0 %id)
BG768900 melanotic melanoma, high MDR (cell line), skin .a 164 to 871 1 to 708       708/708
(100 %)
5 diff
(99.3 %id)
BQ224465 melanotic melanoma, skin .a 164 to 847 1 to 690       690/755
(91 %)
11 diff
(98.6 %id)
BQ222071 embryonal carcinoma, cell line, testis .a 168 to 1000 1 to 842       842/872
(96 %)
16 diff
(98.2 %id)
BX403911 neuroblastoma .a 172 to 1207 1 to 1031       1031/1050
(98 %)
30 diff
(97.2 %id)
AL529478 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 1281 to 2396 1105 to 1       1105/1105
(100 %)
26 diff
(97.7 %id)
BX453981 neuroblastoma .a 1738 to 2404 668 to 1       668/668
(100 %)
50 diff
(92.6 %id)
AI937907 brain, frontal lobe .a 1974 to 2424 465 to 15   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 451/451
(100 %)
0 diff
(100 %id)
NM_001048194.1   .b 1 to 2532 1 to 2532 exact RefSeq,   2532/2532
(100 %)
0 diff
(100 %id)
BP313431 mammary gland .b 9 to 590 1 to 583       583/583
(100 %)
5 diff
(99.2 %id)
BP313466 mammary gland .b 9 to 590 1 to 582   tiling clone,   582/582
(100 %)
0 diff
(100 %id)
AL552883 placenta, Placenta Cot 25-normalized .b 30 to 995 7 to 967       961/1027
(93 %)
18 diff
(98.3 %id)
BC069198 Breast, adenocarcinoma .b 36 to 1601 1 to 1566   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1566/1566
(100 %)
0 diff
(100 %id)
BU539399 adenocarcinoma, cell line, breast .b 37 to 921 1 to 898       898/924
(97 %)
21 diff
(97.8 %id)
BU557974 adenocarcinoma, cell line, breast .b 44 to 956 1 to 918       918/924
(99 %)
30 diff
(96.8 %id)
S75708   .b 140 to 277 1 to 138       138/138
(100 %)
0 diff
(100 %id)
AL552836 placenta, Placenta Cot 25-normalized .b 1391 to 2391 987 to 1   tiling clone,   987/1043
(94 %)
24 diff
(97.7 %id)
NM_001048195.1   .c 1 to 2490 1 to 2490 exact RefSeq,   2490/2490
(100 %)
0 diff
(100 %id)
DB453393 testis .c 23 to 534 1 to 512   tiling clone,   512/512
(100 %)
1 diff
(99.9 %id)
BM462376 leiomyosarcoma, uterus .c 23 to 963 1 to 948       947/1052
(90 %)
52 diff
(95.1 %id)
CV811053 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 30 to 780 1 to 750       750/750
(100 %)
2 diff
(99.8 %id)
BQ436549 melanotic melanoma, skin .c 43 to 801 23 to 782       760/862
(88 %)
15 diff
(98.3 %id)
CN366100 embryonic stem cells, DMSO-treated H9 cellline .c 55 to 618 9 to 573       565/573
(98 %)
8 diff
(98.7 %id)
BG335845 choriocarcinoma, placenta .c 67 to 772 2 to 705       702/883
(79 %)
26 diff
(97.1 %id)
BG336295 choriocarcinoma, placenta .c 67 to 675 2 to 609       608/1001
(60 %)
2 diff
(99.9 %id)
CA976108 sciatic nerve .c 76 to 927 12 to 880       869/946
(91 %)
42 diff
(95.6 %id)
BQ420403 embryonal carcinoma, cell line, testis .c 90 to 1087 1 to 999   tiling clone,   999/1110
(90 %)
41 diff
(96.4 %id)
BM546148 ovary (pool of 3) .c 147 to 1202 21 to 1076   tiling clone,   1056/1078
(97 %)
25 diff
(97.7 %id)
BG337685 leiomyosarcoma cell line, uterus .c 158 to 934 7 to 771       731/909
(80 %)
22 diff
(97.6 %id)
NR_030725.1   .d 1 to 2858 1 to 2858 exact RefSeq, tiling clone,   2858/2858
(100 %)
0 diff
(100 %id)
BP284402 bone marrow .d 101 to 687 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
X06130   .d 102 to 1825 1 to 1724 exact     1724/1724
(100 %)
0 diff
(100 %id)
BU170087 embryonal carcinoma, cell line, testis .d 114 to 939 1 to 835       835/921
(90 %)
14 diff
(98.5 %id)
BM913989 astrocytoma grade IV, cell line, brain .d 115 to 762 1 to 652       652/1170
(55 %)
16 diff
(98.7 %id)
BF794286 lymph, lymphoma, cell line .d 116 to 845 1 to 727       727/917
(79 %)
12 diff
(98.7 %id)
BI226601 Burkitt lymphoma, lymph .d 116 to 859 1 to 739       741/740
(100 %)
20 diff
(97.3 %id)
BQ228695 embryonal carcinoma, cell line, testis .d 134 to 1017 1 to 886       886/886
(100 %)
4 diff
(99.6 %id)
BM561711 duodenal adenocarcinoma, cell line, small intestine .d 144 to 1063 1 to 920       920/994
(92 %)
5 diff
(99.5 %id)
BG328703 adenocarcinoma cell line, colon .d 168 to 599 37 to 474       438/477
(91 %)
21 diff
(95.6 %id)
NM_001048199.2   .e 1 to 2715 1 to 2715 exact RefSeq,   2715/2715
(100 %)
0 diff
(100 %id)
BU501614 brain, neuroblastoma, cell line .e 48 to 950 1 to 903   tiling clone,   903/903
(100 %)
7 diff
(99.3 %id)
BP364765 lung .e 101 to 682 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BX343520 Neuroblastoma Cot 25-normalized .e 117 to 921 1 to 805   tiling clone,   805/805
(100 %)
1 diff
(99.9 %id)
BX376198 Neuroblastoma Cot 25-normalized .e 117 to 1137 1 to 1011   tiling clone,   1013/1057
(95 %)
19 diff
(98.3 %id)
NR_030726.1   .f 1 to 2854 1 to 2854 exact RefSeq, tiling clone,   2854/2854
(100 %)
0 diff
(100 %id)
BG472190 eye, retinoblastoma .f 113 to 841 1 to 735       735/778
(94 %)
16 diff
(98.0 %id)
BG472768 eye, retinoblastoma .f 113 to 618 1 to 510       510/510
(100 %)
11 diff
(97.9 %id)
BC007300 Eye, retinoblastoma .f 114 to 2641 1 to 2528 exact available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2528/2528
(100 %)
1 diff
(100.0 %id)
BC036903 Testis, embryonal carcinoma .f 115 to 1895 12 to 1792 exact available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1781/1781
(100 %)
0 diff
(100 %id)
TI_57195940   .f 127 to 841 29 to 744       716/748
(95 %)
8 diff
(99.0 %id)
BI818114 pooled brain, lung, testis .f 128 to 841 1 to 715       715/719
(99 %)
2 diff
(99.8 %id)
BM560408 brain, medulla .f 244 to 1224 33 to 1036       1004/1103
(91 %)
44 diff
(96.1 %id)
BE542980 cervix .f 245 to 806 1 to 572       572/572
(100 %)
43 diff
(92.5 %id)
BG392657 embryonal carcinoma, cell line, testis .f 386 to 1060 1 to 671       672/686
(97 %)
16 diff
(97.7 %id)
BM474310 leiomyosarcoma, uterus .f 387 to 1226 1 to 842       842/1025
(82 %)
13 diff
(98.8 %id)
BE271245 Burkitt lymphoma, lymph .f 389 to 1217 10 to 839   available from MGC,   830/877
(94 %)
27 diff
(97.0 %id)
BE270545 Burkitt lymphoma, lymph .f 389 to 1059 39 to 710       672/787
(85 %)
16 diff
(98.0 %id)
BF304763 muscle, rhabdomyosarcoma .f 396 to 829 1 to 440       440/1016
(43 %)
14 diff
(98.7 %id)
BI114993 muscle, rhabdomyosarcoma .f 396 to 938 1 to 550       550/558
(98 %)
23 diff
(95.9 %id)
BC010067 Muscle, rhabdomyosarcoma .f 397 to 2641 1 to 2246 exact available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2246/2246
(100 %)
1 diff
(100.0 %id)
AF498924 brain .f 400 to 1665 1 to 1266 exact     1266/1266
(100 %)
0 diff
(100 %id)
CR407693   .f 400 to 1662 1 to 1263       1263/1263
(100 %)
0 diff
(100 %id)
CV027115 mixed .f 400 to 1015 1 to 616       616/616
(100 %)
0 diff
(100 %id)
TI_1948126950   .f 400 to 1217 134 to 942       809/1072
(75 %)
40 diff
(96.3 %id)
TI_1948126951   .f 400 to 1223 136 to 963       828/1214
(68 %)
23 diff
(98.2 %id)
TI_1948127269   .f 400 to 1194 126 to 909       784/1054
(74 %)
47 diff
(95.6 %id)
TI_1948127270   .f 400 to 1312 129 to 1053       923/1224
(75 %)
40 diff
(96.8 %id)
TI_1948127583   .f 400 to 1223 132 to 959       828/1096
(75 %)
37 diff
(96.7 %id)
TI_1948127584   .f 400 to 1118 132 to 858       723/1276
(56 %)
28 diff
(97.9 %id)
TI_1948127889   .f 400 to 1059 130 to 789       660/1080
(61 %)
28 diff
(97.5 %id)
TI_1948127890   .f 400 to 1184 134 to 927       794/1313
(60 %)
48 diff
(96.4 %id)
BE266024 lung, small cell carcinoma .f 406 to 1034 1 to 634       634/634
(100 %)
26 diff
(95.9 %id)
BU177891 melanotic melanoma, skin .f 413 to 1226 1 to 825       825/885
(93 %)
22 diff
(97.6 %id)
BM720744 eye, fetal eye .f 521 to 1266 1 to 746     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 746/746
(100 %)
1 diff
(99.9 %id)
BI045871 prostate_normal .f 534 to 1096 1 to 563       563/563
(100 %)
8 diff
(98.6 %id)
BI046231 prostate_normal .f 534 to 1039 1 to 505       506/505
(100 %)
4 diff
(99.3 %id)
BI046060 prostate_normal .f 548 to 1159 1 to 618       617/618
(99 %)
31 diff
(95.0 %id)
BQ060116 lymph, lymphoma, cell line .f 565 to 1319 21 to 781       761/961
(79 %)
13 diff
(98.7 %id)
BQ642961 lymph, lymphoma, cell line .f 570 to 1381 1 to 813       813/956
(85 %)
14 diff
(98.6 %id)
BU522008 leiomyosarcoma, uterus .f 603 to 1379 1 to 785       785/889
(88 %)
11 diff
(98.8 %id)
BP246617 Kidney .f 637 to 1219 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BE562086 Burkitt lymphoma, lymph .f 639 to 1495 30 to 885       856/921
(92 %)
42 diff
(95.5 %id)
AW732750 Burkitt lymphoma, lymph .f 644 to 1286 1 to 644       644/644
(100 %)
17 diff
(97.4 %id)
BY997551   .f 645 to 1323 1 to 678       678/678
(100 %)
5 diff
(99.3 %id)
TI_1948127271   .f 655 to 1669 1135 to 122       1014/1229
(82 %)
23 diff
(98.2 %id)
BE270499 Burkitt lymphoma, lymph .f 658 to 1095 41 to 479       439/484
(90 %)
7 diff
(98.6 %id)
BI046714 prostate_normal .f 662 to 1196 1 to 535       535/535
(100 %)
18 diff
(96.7 %id)
TI_1948126952   .f 666 to 1669 1139 to 121       1019/1259
(80 %)
42 diff
(96.7 %id)
BE396572 Burkitt lymphoma, lymph .f 674 to 1180 1 to 507       507/508
(99 %)
1 diff
(99.9 %id)
BU188198 leiomyosarcoma, uterus .f 716 to 1497 1 to 785       785/878
(89 %)
13 diff
(98.6 %id)
BE707928 head_neck .f 717 to 818 1 to 102       102/102
(100 %)
2 diff
(98.1 %id)
TI_1948126953   .f 724 to 1669 1055 to 121       935/1063
(87 %)
28 diff
(97.4 %id)
BE831173 marrow .f 758 to 1223 468 to 3       466/468
(99 %)
0 diff
(100 %id)
TI_1948127585   .f 824 to 1669 967 to 119       849/1298
(65 %)
18 diff
(98.7 %id)
CA395647 eye, RPE/choroid .f 829 to 1343 1 to 515       515/519
(99 %)
5 diff
(99.1 %id)
TI_1948127586   .f 835 to 1669 963 to 123       841/1078
(78 %)
15 diff
(98.7 %id)
AA316333 colon .f 852 to 1165 1 to 313       313/313
(100 %)
3 diff
(99.1 %id)
CN366102 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 873 to 1393 1 to 521       521/521
(100 %)
2 diff
(99.7 %id)
TI_57173450   .f 900 to 1709 23 to 838       816/841
(97 %)
22 diff
(97.4 %id)
BI826337 brain, medulla .f 905 to 1709 1 to 811       811/814
(99 %)
16 diff
(98.1 %id)
TI_57190213   .f 945 to 1836 50 to 945       896/899
(99 %)
40 diff
(95.6 %id)
BI856344 breast, mammary adenocarcinoma, cell line .f 946 to 1836 1 to 895       895/898
(99 %)
40 diff
(95.6 %id)
CV816189 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 946 to 1829 1 to 889       889/898
(98 %)
20 diff
(97.8 %id)
BE074640 breast .f 956 to 1310 355 to 1     Submitted on the opposite strand 355/363
(97 %)
3 diff
(99.2 %id)
BE074825 breast .f 956 to 1310 355 to 1     Submitted on the opposite strand 355/363
(97 %)
3 diff
(99.2 %id)
TI_1948127272   .f 962 to 1669 832 to 124       709/1078
(65 %)
13 diff
(98.8 %id)
TI_1948127892   .f 966 to 1669 828 to 122       707/1070
(66 %)
8 diff
(99.3 %id)
BM852404 Ascites, stomach .f 967 to 1525 1 to 559       559/559
(100 %)
3 diff
(99.5 %id)
BI834318 pooled pancreas and spleen .f 1002 to 1832 1 to 839       839/840
(99 %)
20 diff
(97.7 %id)
TI_57163864   .f 1002 to 1832 30 to 868       839/869
(96 %)
25 diff
(97.2 %id)
BQ378891 uterus_tumor .f 1055 to 1589 1 to 542       540/542
(99 %)
27 diff
(95.1 %id)
BQ378836 uterus_tumor .f 1056 to 1530 1 to 475       475/475
(100 %)
1 diff
(99.8 %id)
BQ378876 uterus_tumor .f 1076 to 1647 581 to 1       590/581
(101 %)
58 diff
(90.1 %id)
BM799010 Ascites, stomach .f 1082 to 1517 1 to 436       436/436
(100 %)
2 diff
(99.6 %id)
BP225184   .f 1094 to 1672 1 to 579       579/582
(99 %)
11 diff
(98.2 %id)
DB108135 thymus .f 1120 to 1690 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BM836513 Ascites, stomach .f 1156 to 1614 1 to 459       459/459
(100 %)
1 diff
(99.8 %id)
BM795282 stomach .f 1158 to 1753 1 to 597       597/597
(100 %)
1 diff
(99.9 %id)
CX760166 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 1180 to 1892 1 to 704       704/864
(81 %)
14 diff
(98.4 %id)
BM050695 eye, normal pigmented retinal epithelium .f 1192 to 1820 1 to 629       629/669
(94 %)
5 diff
(99.3 %id)
TI_59392333   .f 1346 to 1903 97 to 654       558/558
(100 %)
1 diff
(99.9 %id)
BM014318 breast, mammary adenocarcinoma, cell line .f 1347 to 1903 1 to 557       557/557
(100 %)
1 diff
(99.9 %id)
BF033972 adenocarcinoma, ovary .f 1358 to 2160 1 to 795       795/871
(91 %)
32 diff
(96.4 %id)
D82181   .f 1360 to 1749 1 to 390       390/390
(100 %)
2 diff
(99.5 %id)
BM476944 leiomyosarcoma, uterus .f 1442 to 2380 1 to 955       955/1061
(90 %)
36 diff
(96.7 %id)
BE744942 adenocarcinoma cell line, ovary .f 1471 to 2234 1 to 757       757/961
(78 %)
16 diff
(98.4 %id)
AW062531 colon .f 1488 to 2077 590 to 2       589/708
(83 %)
0 diff
(100 %id)
BQ309066 breast .f 1489 to 1929 453 to 1       453/508
(89 %)
29 diff
(94.3 %id)
AW838015 leiomios .f 1490 to 1774 284 to 1       284/284
(100 %)
2 diff
(99.3 %id)
BX354721 Neuroblastoma Cot 25-normalized .f 1496 to 2618 1113 to 1       1113/1113
(100 %)
19 diff
(98.3 %id)
BF769774 epid_tumor .f 1518 to 1809 292 to 1     Submitted on the opposite strand 292/292
(100 %)
2 diff
(99.4 %id)
BQ308477 breast .f 1566 to 1789 233 to 10       224/238
(94 %)
0 diff
(100 %id)
BQ307924 breast .f 1570 to 1932 373 to 12       362/373
(97 %)
0 diff
(100 %id)
F05487 brain, total brain .f 1592 to 1881 1 to 290       290/290
(100 %)
0 diff
(100 %id)
F13376 brain, total brain .f 1592 to 1932 1 to 342       342/342
(100 %)
1 diff
(99.8 %id)
BF820901 kidney_tumor .f 1596 to 2007 1 to 412       412/423
(97 %)
1 diff
(99.8 %id)
BX335430 Placenta Cot 25-normalized .f 1600 to 2608 1007 to 1       1007/1007
(100 %)
4 diff
(99.7 %id)
T77186 whole brain .f 1617 to 2065 1 to 469       469/474
(98 %)
32 diff
(93.3 %id)
BM824409 Ascites, stomach .f 1647 to 2155 1 to 509       509/509
(100 %)
0 diff
(100 %id)
AL119883 amygdala .f 1650 to 2157 1 to 508       508/508
(100 %)
0 diff
(100 %id)
AA142907 uterus .f 1657 to 2233 11 to 571       561/617
(90 %)
28 diff
(95.5 %id)
AW374346 colon .f 1677 to 1943 15 to 278       264/314
(84 %)
10 diff
(96.9 %id)
AA291608 ovarian tumor, ovary .f 1684 to 2106 1 to 418   fully sequenced,   418/418
(100 %)
3 diff
(99.3 %id)
AA477596 ovarian tumor, ovary .f 1684 to 2273 1 to 588       588/588
(100 %)
12 diff
(98.0 %id)
BX109495 ovarian tumor, ovary .f 1685 to 2423 1 to 740       740/742
(99 %)
3 diff
(99.6 %id)
AI215010   .f 1690 to 2103 408 to 3       406/408
(99 %)
0 diff
(100 %id)
BX343519 Neuroblastoma Cot 25-normalized .f 1760 to 2587 828 to 1       828/828
(100 %)
3 diff
(99.7 %id)
AA482399 ovarian tumor, ovary .f 1775 to 2370 1 to 595       595/595
(100 %)
8 diff
(98.7 %id)
BG329590 eye, retinoblastoma .f 1860 to 2421 1 to 561       561/1051
(53 %)
5 diff
(99.6 %id)
BU165581 eye, retinoblastoma .f 1870 to 2638 1 to 784       784/934
(83 %)
34 diff
(96.4 %id)
AA313518 colon .f 1875 to 2272 1 to 398       398/398
(100 %)
0 diff
(100 %id)
AW951929   .f 1876 to 2230 1 to 355       355/355
(100 %)
8 diff
(97.8 %id)
BQ323131 colon_est .f 1876 to 2220 1 to 347       347/347
(100 %)
17 diff
(95.2 %id)
AW993543 breast_normal .f 1889 to 2108 7 to 226       220/226
(97 %)
6 diff
(97.4 %id)
AA037600 uterus .f 1901 to 2342 1 to 457       457/460
(99 %)
21 diff
(95.5 %id)
TI_149296739   .f 1930 to 2646 800 to 88   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 713/789
(90 %)
13 diff
(98.4 %id)
AA776373   .f 1943 to 2641 720 to 21   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 700/700
(100 %)
51 diff
(92.8 %id)
AI568844 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .f 1969 to 2641 689 to 24   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 666/666
(100 %)
29 diff
(95.7 %id)
BQ446933 Knee, Osteoarthritic Cartilage .f 1981 to 2641 675 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 659/659
(100 %)
3 diff
(99.6 %id)
BX404402 neuroblastoma .f 1991 to 2645 1 to 655       655/655
(100 %)
0 diff
(100 %id)
AI889063 anaplastic oligodendroglioma, brain .f 2010 to 2641 630 to 1       630/653
(96 %)
8 diff
(98.8 %id)
BE871033 adenocarcinoma, colon .f 2013 to 2643 1 to 629       629/629
(100 %)
4 diff
(99.4 %id)
BG179694 adenocarcinoma, cell line, Prostate .f 2015 to 2625 1 to 612       612/743
(82 %)
5 diff
(99.4 %id)
BM993816 Bone, Subchondral Bone .f 2016 to 2647 644 to 18       627/644
(97 %)
0 diff
(100 %id)
CN479348 Bone, Subchondral Bone .f 2016 to 2647 644 to 18       627/644
(97 %)
0 diff
(100 %id)
BU624721 cell lines, Enchondroma .f 2027 to 2646 637 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 619/619
(100 %)
1 diff
(99.9 %id)
TI_154132824   .f 2031 to 2641 712 to 99   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 614/833
(73 %)
8 diff
(99.1 %id)
TI_149314544   .f 2033 to 2847 914 to 115   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 800/927
(86 %)
18 diff
(98.1 %id)
TI_154144297   .f 2034 to 2434 87 to 487       401/529
(75 %)
2 diff
(99.7 %id)
BM676856 eye, fetal eye .f 2039 to 2646 621 to 14   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 608/608
(100 %)
3 diff
(99.6 %id)
BM969259 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 2040 to 2646 620 to 14   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 607/607
(100 %)
2 diff
(99.7 %id)
BU622451 cell lines, Chondrosarcoma .f 2058 to 2753 713 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 695/695
(100 %)
1 diff
(99.9 %id)
T82936 liver and spleen .f 2069 to 2348 1 to 287       287/296
(96 %)
11 diff
(96.3 %id)
T83100 liver and spleen .f 2069 to 2315 1 to 251   fully sequenced,   251/251
(100 %)
4 diff
(98.5 %id)
AA291398 ovarian tumor, ovary .f 2076 to 2640 565 to 1   fully sequenced,   565/565
(100 %)
1 diff
(99.9 %id)
AW575333 lymph .f 2082 to 2641 575 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 560/560
(100 %)
1 diff
(99.9 %id)
BQ229555 embryonal carcinoma, cell line, testis .f 2084 to 2639 32 to 587   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 556/587
(94 %)
6 diff
(99.0 %id)
FN112845 breast carcinoma .f 2099 to 2157 60 to 1     Submitted on the opposite strand 60/61
(98 %)
1 diff
(98.4 %id)
AA729226 pooled germ cell tumors .f 2127 to 2648 521 to 1       521/521
(100 %)
7 diff
(98.7 %id)
AA687470 germinal center B cell .f 2129 to 2645 522 to 6       517/536
(96 %)
0 diff
(100 %id)
AI266488 placenta .f 2136 to 2641 520 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 505/537
(94 %)
16 diff
(97.1 %id)
BI334903 cervical carcinoma cell line, cervix .f 2151 to 2646 7 to 500   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 494/500
(98 %)
6 diff
(98.8 %id)
BI333702 cervical carcinoma cell line, cervix .f 2151 to 2652 7 to 506       500/585
(85 %)
12 diff
(98.0 %id)
AI598255 anaplastic oligodendroglioma, brain .f 2157 to 2753 597 to 1       597/597
(100 %)
1 diff
(99.9 %id)
BF109811 pooled .f 2157 to 2645 489 to 1       489/489
(100 %)
0 diff
(100 %id)
AI095944 uterus .f 2163 to 2590 428 to 1       428/428
(100 %)
1 diff
(99.8 %id)
AA977522 pooled .f 2182 to 2641 460 to 1       460/460
(100 %)
0 diff
(100 %id)
AA533561 ovary .f 2188 to 2639 453 to 1       453/453
(100 %)
7 diff
(98.5 %id)
CB851656 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 2196 to 2847 670 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 652/652
(100 %)
5 diff
(99.3 %id)
DB519727 testis .f 2198 to 2641 1 to 444     Submitted on the opposite strand 444/444
(100 %)
2 diff
(99.6 %id)
DB519679 testis .f 2211 to 2646 1 to 436   AAA Submitted on the opposite strand 436/436
(100 %)
3 diff
(99.4 %id)
AA923745 pooled .f 2222 to 2741 522 to 3       520/522
(99 %)
0 diff
(100 %id)
BU502318 mixed (pool of 40 RNAs) .f 2223 to 2642 1 to 418       418/422
(99 %)
4 diff
(99.1 %id)
AI989452 brain, three pooled meningiomas .f 2232 to 2641 410 to 1       410/410
(100 %)
0 diff
(100 %id)
AI440211 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 2237 to 2642 406 to 1       406/406
(100 %)
7 diff
(98.3 %id)
AA100241 brain, neuroepithelial cells .f 2238 to 2559 331 to 1       331/331
(100 %)
11 diff
(96.7 %id)
BI090288 cervix .f 2258 to 2645 1 to 393       393/411
(95 %)
7 diff
(98.3 %id)
DB518870 testis .f 2277 to 2741 1 to 465     Submitted on the opposite strand 465/469
(99 %)
1 diff
(99.8 %id)
AI363413 anaplastic oligodendroglioma, brain .f 2284 to 2753 469 to 1       469/469
(100 %)
5 diff
(99.0 %id)
T90563 liver and spleen .f 2285 to 2652 377 to 2   fully sequenced,   376/377
(99 %)
10 diff
(97.4 %id)
AA678439   .f 2291 to 2639 349 to 1       349/349
(100 %)
18 diff
(94.9 %id)
BE855940 Prostate .f 2292 to 2642 352 to 1       352/352
(100 %)
5 diff
(98.6 %id)
AI198971 anaplastic oligodendroglioma, brain .f 2309 to 2753 445 to 1       445/445
(100 %)
0 diff
(100 %id)
CR607152 T cells (Jurkat cell line) Cot10-normalized .f 2330 to 2645 1 to 316       316/316
(100 %)
0 diff
(100 %id)
BX383560   .f 2330 to 2645 1 to 316   fully sequenced,   316/316
(100 %)
0 diff
(100 %id)
AI300205 placenta .f 2339 to 2641 316 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 301/334
(90 %)
13 diff
(96.2 %id)
CN266764 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 2351 to 2613 53 to 315       263/315
(83 %)
6 diff
(98.1 %id)
CN366103 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 2470 to 2647 1 to 178       178/182
(97 %)
2 diff
(99.0 %id)
BX352334   .f 2472 to 2645 174 to 1   fully sequenced,   174/174
(100 %)
4 diff
(97.8 %id)
R39441 whole brain .f 2484 to 2639 156 to 1       156/156
(100 %)
2 diff
(98.8 %id)
BF590413 Kidney .f 2532 to 2854 323 to 1       323/323
(100 %)
0 diff
(100 %id)
F01754 brain, total brain .f 2573 to 2854 282 to 1       282/282
(100 %)
0 diff
(100 %id)
F10967 brain, total brain .f 2590 to 2854 265 to 1       265/265
(100 %)
0 diff
(100 %id)
DB454243 testis .g 1 to 479 1 to 479   tiling clone,   479/479
(100 %)
2 diff
(99.6 %id)
TI_57175328   .g 207 to 1123 26 to 953   tiling clone,   928/955
(97 %)
36 diff
(96.3 %id)
BI828628 brain, medulla .g 210 to 1123 1 to 925   tiling clone,   925/927
(99 %)
26 diff
(97.2 %id)
BM917308 blood, natural killer cells, cell line .h 1 to 549 1 to 550       550/1323
(41 %)
13 diff
(99.1 %id)
BQ052810 blood, natural killer cells, cell line .h 1 to 924 1 to 937 N249H R253P Q254A E257X K263Q ... tiling clone,   937/1079
(86 %)
29 diff
(97.4 %id)
BQ053548 blood, natural killer cells, cell line .h 1 to 935 1 to 945 K212X Q254A G255R L256P E257R ... tiling clone,   945/1026
(92 %)
20 diff
(98.1 %id)
TI_57172107   .i 1 to 887 24 to 906   tiling clone,   883/906
(97 %)
30 diff
(96.7 %id)
BM552911 brain, medulla .i 3 to 1061 20 to 1089 G180X G197X C198L G199R L210X ... tiling clone,   1070/1136
(94 %)
31 diff
(97.3 %id)
BI831360 brain, medulla .i 5 to 887 1 to 879   tiling clone,   879/879
(100 %)
23 diff
(97.4 %id)
BM478200 lymph, lymphoma, cell line .j 1 to 802 1 to 807   tiling clone,   807/1035
(77 %)
7 diff
(99.4 %id)
BI259888 cervical carcinoma cell line, cervix .j 299 to 1070 1 to 772   tiling clone,   772/773
(99 %)
3 diff
(99.7 %id)
BE744540 adenocarcinoma cell line, ovary .k 1 to 800 1 to 795 P192L A193L V194S S195P S196R ... tiling clone,   795/988
(80 %)
27 diff
(97.3 %id)
BM548730 duodenal adenocarcinoma, cell line, small intestine .l 1 to 736 1 to 743 G168X G193R F199I N201H Q206A ... tiling clone,   743/1037
(71 %)
23 diff
(97.8 %id)
DB454286 testis .m 1 to 481 1 to 481 exact tiling clone,   481/481
(100 %)
0 diff
(100 %id)
BE718176 head_neck .n 1 to 540 1 to 539 V12C C13V L14* tiling clone,   539/539
(100 %)
3 diff
(99.5 %id)
AL134800 brain .o 1 to 509 1 to 509   tiling clone,   509/509
(100 %)
0 diff
(100 %id)
BE545928 cervical carcinoma cell line, cervix .o 166 to 875 1 to 713   tiling clone,   713/938
(76 %)
39 diff
(95.9 %id)
CX760120 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .o 176 to 701 1 to 525     Submitted on the opposite strand 525/687
(76 %)
30 diff
(95.7 %id)
BG165379 hypernephroma, cell line, Kidney .o 185 to 848 1 to 664   tiling clone,   664/665
(99 %)
11 diff
(98.4 %id)
CN366104 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .o 208 to 574 1 to 368       368/368
(100 %)
1 diff
(99.8 %id)
DA135739 alzheimer cortex .p 1 to 539 2 to 540 exact tiling clone, capped   539/539
(100 %)
1 diff
(99.9 %id)
BU619936 cell lines, Chondrosarcoma .p 540 to 851 328 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 310/320
(96 %)
10 diff
(96.9 %id)
AW603639 colon_normal .q-u 1 to 532 1 to 533   tiling clone,   533/533
(100 %)
18 diff
(96.7 %id)
AW603697 colon_normal .q-u 285 to 929 665 to 20 G12V tiling clone,   646/666
(96 %)
0 diff
(100 %id)
AW603650 colon_normal .q-u 289 to 922 635 to 3 T10A tiling clone,   633/635
(99 %)
0 diff
(100 %id)
BF667678 brain, primitive neuroectoderm .r 1 to 611 1 to 606 L27S S28L P29L F30L W31E ... tiling clone,   606/809
(74 %)
26 diff
(96.8 %id)
NR_002909.1   .r 43 to 981 1 to 939   RefSeq, tiling clone,   939/939
(100 %)
0 diff
(100 %id)
DA044266 bladder .r 44 to 593 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA056610 cerebellum .r 44 to 599 2 to 556   capped   555/555
(100 %)
3 diff
(99.5 %id)
DA089660 cerebellum .r 44 to 621 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
CB963044 Blood vessels - aorta, basilar and artery .r 48 to 809 1 to 761       761/818
(93 %)
10 diff
(98.8 %id)
DA998284   .r 97 to 665 2 to 572   capped   571/571
(100 %)
6 diff
(99.0 %id)
BU198833   .r 99 to 769 1 to 671       671/671
(100 %)
15 diff
(97.8 %id)
CB985655 Pooled-Glandular .r 99 to 891 1 to 811       811/882
(91 %)
30 diff
(96.6 %id)
BU943197 mixed (pool of 40 RNAs) .r 100 to 868 1 to 774       774/779
(99 %)
11 diff
(98.6 %id)
DA969742 stomach .r 100 to 662 2 to 565   capped   564/564
(100 %)
4 diff
(99.3 %id)
BG531550 embryonal carcinoma, testis .r 101 to 758 1 to 660       660/666
(99 %)
34 diff
(94.9 %id)
AJ006834   .r 102 to 986 1 to 885       885/885
(100 %)
0 diff
(100 %id)
AJ006835   .r 102 to 2239 1 to 2138   tiling clone,   2138/2139
(99 %)
1 diff
(100.0 %id)
BG499865 adenocarcinoma, Prostate .r 102 to 744 1 to 641       641/642
(99 %)
16 diff
(97.6 %id)
BM759606 Ascites, stomach .r 102 to 771 1 to 670       670/670
(100 %)
0 diff
(100 %id)
BF695893 brain, primitive neuroectoderm .r 103 to 841 1 to 726       731/726
(100 %)
88 diff
(87.9 %id)
BM771983 stomach .r 103 to 721 1 to 619       619/619
(100 %)
3 diff
(99.6 %id)
BM847729 myeloma .r 103 to 489 1 to 387       387/387
(100 %)
0 diff
(100 %id)
DA943290 Spleen .r 103 to 668 2 to 568   capped   567/568
(99 %)
2 diff
(99.7 %id)
DA955189 Spleen .r 103 to 614 2 to 515   capped   514/514
(100 %)
3 diff
(99.5 %id)
DB157161 thymus .r 103 to 679 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
DA224254 brain .r 104 to 678 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
CD048541 embryonic stem cells, WA01, passage 38 .r 104 to 971 22 to 894       873/904
(96 %)
20 diff
(97.8 %id)
DA478694   .r 104 to 675 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA510712 brain .r 104 to 563 2 to 462   capped   461/461
(100 %)
1 diff
(99.8 %id)
DA565956 heart .r 104 to 671 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA644956   .r 104 to 675 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA652687   .r 104 to 680 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
DA704998   .r 104 to 599 2 to 497   capped   496/496
(100 %)
0 diff
(100 %id)
DA728986   .r 104 to 819 2 to 718   capped   717/724
(99 %)
12 diff
(98.4 %id)
DA787816 brain .r 104 to 617 2 to 515   capped   514/514
(100 %)
1 diff
(99.9 %id)
DA813306   .r 104 to 466 2 to 364   capped   363/363
(100 %)
0 diff
(100 %id)
DA817644   .r 104 to 678 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA847021 placenta .r 104 to 672 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA916515 small intestine .r 104 to 679 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
DA918003 small intestine .r 104 to 681 2 to 580   capped   579/582
(99 %)
2 diff
(99.7 %id)
DA922155 small intestine .r 104 to 667 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA925005 small intestine .r 104 to 666 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
DA926278 small intestine .r 104 to 681 2 to 580   capped   579/580
(99 %)
3 diff
(99.5 %id)
DA931069 small intestine .r 104 to 692 2 to 590   capped   589/589
(100 %)
4 diff
(99.4 %id)
DA932306 Spleen .r 104 to 674 2 to 572   capped   571/571
(100 %)
3 diff
(99.5 %id)
DA936462 Spleen .r 104 to 678 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA952260 Spleen .r 104 to 660 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA961704 Spleen .r 104 to 650 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DA968918 stomach .r 104 to 678 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB112428 thymus .r 104 to 700 2 to 599   capped   598/598
(100 %)
2 diff
(99.7 %id)
DB113121 thymus .r 104 to 676 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DB128729 thymus .r 104 to 673 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB262011 uterus .r 104 to 677 2 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
DB271395 uterus .r 104 to 642 2 to 541   capped   540/540
(100 %)
2 diff
(99.7 %id)
DA902617   .r 105 to 644 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DA820174 pericardium .r 106 to 668 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA928567 small intestine .r 107 to 681 2 to 577   capped   576/579
(99 %)
2 diff
(99.7 %id)
BF941702 fibrotheoma, ovary .r 109 to 499 1 to 390     Submitted on the opposite strand 390/391
(99 %)
3 diff
(99.3 %id)
CB128113 Liver .r 109 to 566 10 to 467       458/458
(100 %)
1 diff
(99.8 %id)
AV763089 bone marrow .r 109 to 846 1 to 734       734/800
(91 %)
43 diff
(94.7 %id)
AV764560 bone marrow .r 110 to 759 1 to 642       642/643
(99 %)
8 diff
(98.8 %id)
CN366535 embryonic stem cells, DMSO-treated H9 cellline .r 112 to 836 1 to 725       725/725
(100 %)
1 diff
(99.9 %id)
BG474710 eye, retinoblastoma .r 113 to 981 1 to 871   available from MGC,   871/878
(99 %)
29 diff
(96.7 %id)
CN366538 embryonic stem cells, cell lines H1, H7, andH9 .r 114 to 835 13 to 734       722/734
(98 %)
6 diff
(99.2 %id)
CN366543 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .r 114 to 713 9 to 609       601/609
(98 %)
7 diff
(98.9 %id)
BC012122 Eye, retinoblastoma .r 114 to 980 1 to 867   available from MGC, AAA   867/867
(100 %)
2 diff
(99.8 %id)
BQ224438 large cell carcinoma, lung .r 114 to 964 12 to 862       851/862
(98 %)
8 diff
(99.1 %id)
BC065008 Skin, melanotic melanoma. .r 114 to 980 1 to 867   available from MGC, AAA   867/867
(100 %)
0 diff
(100 %id)
CB157773 Liver .r 114 to 568 1 to 455       455/455
(100 %)
0 diff
(100 %id)
BF795420 lymph, lymphoma, cell line .r 115 to 827 1 to 710       710/914
(77 %)
11 diff
(98.8 %id)
BG115368 duodenal adenocarcinoma, cell line, small intestine .r 115 to 555 1 to 453       453/453
(100 %)
23 diff
(95.0 %id)
BM802102 duodenal adenocarcinoma, cell line, small intestine .r 115 to 677 1 to 571       571/1018
(56 %)
11 diff
(99.0 %id)
BM802666 eye, retinoblastoma .r 115 to 980 1 to 870   AAA   870/870
(100 %)
8 diff
(99.1 %id)
BU183513 melanotic melanoma, skin .r 115 to 918 1 to 810   available from MGC,   810/855
(94 %)
19 diff
(97.8 %id)
BM790281 Ascites, stomach .r 115 to 670 1 to 556       556/556
(100 %)
0 diff
(100 %id)
CN366537 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .r 116 to 416 1 to 302       302/302
(100 %)
4 diff
(98.7 %id)
BG028447 Bone, osteosarcoma, cell line .r 116 to 794 1 to 669       669/741
(90 %)
15 diff
(98.0 %id)
TI_57179009   .r 116 to 840 32 to 750       719/753
(95 %)
19 diff
(97.5 %id)
TI_57165820   .r 116 to 878 24 to 777       756/777
(97 %)
16 diff
(98.0 %id)
TI_57190177   .r 116 to 793 47 to 722       679/676
(100 %)
22 diff
(96.8 %id)
BG291633 bladder, transitional cell papilloma, cell line .r 117 to 880 1 to 752       754/797
(94 %)
44 diff
(94.5 %id)
BI856309 breast, mammary adenocarcinoma, cell line .r 117 to 793 1 to 675       678/675
(100 %)
22 diff
(96.8 %id)
BM479709 eye, retinoblastoma .r 117 to 981 1 to 865       865/874
(98 %)
10 diff
(98.9 %id)
BI772556 pooled lung and spleen .r 118 to 840 1 to 719       719/722
(99 %)
15 diff
(98.0 %id)
BI833122 pooled pancreas and spleen .r 118 to 898 1 to 781       783/782
(100 %)
13 diff
(98.4 %id)
TI_57168536   .r 118 to 898 32 to 812       783/813
(96 %)
19 diff
(97.7 %id)
BI833284 pooled pancreas and spleen .r 119 to 878 1 to 751       753/751
(100 %)
11 diff
(98.6 %id)
BQ218931 melanotic melanoma, skin .r 119 to 906 1 to 794       794/933
(85 %)
11 diff
(98.9 %id)
CB163464 Liver .r 119 to 675 1 to 557       557/557
(100 %)
0 diff
(100 %id)
BC006790 Cervix, carcinoma .r 120 to 980 1 to 861   available from MGC, AAA   861/861
(100 %)
1 diff
(99.9 %id)
CB123101 Liver .r 120 to 481 1 to 361       361/361
(100 %)
4 diff
(98.9 %id)
BM826599 Ascites, stomach .r 122 to 575 1 to 454       454/454
(100 %)
6 diff
(98.7 %id)
AW674381 cervical carcinoma cell line, cervix .r 123 to 568 1 to 446   available from MGC,   446/446
(100 %)
1 diff
(99.8 %id)
BM450342 eye, retinoblastoma .r 125 to 980 1 to 861   AAA   861/861
(100 %)
15 diff
(98.3 %id)
BE867363 adenocarcinoma, colon .r 126 to 875 1 to 742       745/767
(97 %)
30 diff
(96.1 %id)
BG472887 eye, retinoblastoma .r 126 to 588 1 to 494   available from MGC,   425/494
(86 %)
15 diff
(97.0 %id)
N88534   .r 126 to 505 1 to 378       378/378
(100 %)
8 diff
(97.9 %id)
AA321661   .r 127 to 271 1 to 145       145/145
(100 %)
0 diff
(100 %id)
CN366539 embryonic stem cells, DMSO-treated H9 cellline .r 127 to 589 1 to 463       463/463
(100 %)
0 diff
(100 %id)
BC017334 Eye, retinoblastoma .r 127 to 980 1 to 854   available from MGC, AAA   854/854
(100 %)
1 diff
(99.9 %id)
BG023899 duodenal adenocarcinoma, cell line, small intestine .r 130 to 880 1 to 739       742/951
(78 %)
30 diff
(96.9 %id)
BU187480 eye, retinoblastoma .r 130 to 980 1 to 851   AAA   851/851
(100 %)
6 diff
(99.3 %id)
AL519457 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .r 131 to 980 1 to 851   fully sequenced,   851/851
(100 %)
64 diff
(92.5 %id)
AJ714170 bone marrow .r 132 to 266 1 to 135       135/135
(100 %)
0 diff
(100 %id)
CN366544 embryonic stem cells, DMSO-treated H9 cellline .r 133 to 630 1 to 498       498/498
(100 %)
0 diff
(100 %id)
BY796950 eye .r 134 to 761 1 to 628       628/628
(100 %)
0 diff
(100 %id)
AA358921 lung .r 136 to 474 1 to 339       339/339
(100 %)
1 diff
(99.8 %id)
AJ712759 bone marrow .r 143 to 313 1 to 171       171/171
(100 %)
0 diff
(100 %id)
CN366540 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .r 143 to 768 27 to 650       624/650
(96 %)
9 diff
(98.7 %id)
BF036396 adenocarcinoma, ovary .r 143 to 723 7 to 587       581/587
(98 %)
10 diff
(98.3 %id)
CN366541 embryonic stem cells, DMSO-treated H9 cellline .r 146 to 532 1 to 387       387/387
(100 %)
1 diff
(99.8 %id)
AL519456 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .r 146 to 952 806 to 1   fully sequenced,   806/806
(100 %)
25 diff
(96.9 %id)
CN366536 embryonic stem cells, cell lines H1, H7, andH9 .r 147 to 768 1 to 620       620/622
(99 %)
7 diff
(98.9 %id)
AA352342   .r 152 to 500 1 to 350       350/350
(100 %)
2 diff
(99.5 %id)
AA352343   .r 152 to 510 1 to 362       362/362
(100 %)
3 diff
(99.2 %id)
N40682 placenta .r 153 to 424 1 to 269       269/274
(98 %)
2 diff
(99.3 %id)
BF982554 duodenal adenocarcinoma, cell line, small intestine .r 153 to 927 1 to 759       759/864
(87 %)
22 diff
(97.5 %id)
DA933716 Spleen .r 169 to 706 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
BM828961 stomach .r 214 to 564 1 to 349       349/349
(100 %)
11 diff
(96.9 %id)
BM834932 stomach .r 223 to 687 1 to 464       464/464
(100 %)
1 diff
(99.8 %id)
BE927689 colon .r 301 to 502 1 to 201       201/201
(100 %)
4 diff
(98.1 %id)
CA412573 Chondrosarcoma Grade II, Left Pelvis .r 306 to 979 692 to 19   AAA   674/674
(100 %)
1 diff
(99.9 %id)
BM993043 lung, Metastatic Chondrosarcoma .r 353 to 980 646 to 19   AAA   628/628
(100 %)
0 diff
(100 %id)
CA415535 Chondrosarcoma Grade II, Left Pelvis .r 423 to 980 576 to 19   AAA   558/558
(100 %)
2 diff
(99.7 %id)
EH333588   .r 435 to 510 1 to 75       75/75
(100 %)
1 diff
(98.7 %id)
BE841288 stomach_normal .r 436 to 601 22 to 185       164/185
(88 %)
6 diff
(96.8 %id)
EB387088 eye, optic nerve .r 441 to 980 1 to 540   AAA   540/540
(100 %)
0 diff
(100 %id)
BE142393 head_neck .r 457 to 644 1 to 188       188/188
(100 %)
9 diff
(95.3 %id)
AI829815 lymph node, lymphoma, follicular mixed small and largecell .r 468 to 981 515 to 1       515/515
(100 %)
1 diff
(99.9 %id)
TI_157605054   .r 469 to 980 604 to 94   AAA   511/511
(100 %)
3 diff
(99.5 %id)
CD652956 Embryonic Stem cells .r 475 to 980 1 to 506       506/567
(89 %)
2 diff
(99.7 %id)
H54484 liver and spleen .r 477 to 892 1 to 434       434/434
(100 %)
16 diff
(96.4 %id)
DB362959   .r 485 to 980 496 to 1       496/496
(100 %)
2 diff
(99.6 %id)
BE762374 denis_drash .r 490 to 720 1 to 231       231/231
(100 %)
4 diff
(98.3 %id)
AI921730 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .r 512 to 981 470 to 1       470/470
(100 %)
0 diff
(100 %id)
CR596436 fetal brain .r 514 to 2216 1 to 1703       1703/1703
(100 %)
0 diff
(100 %id)
AL536021 brain, fetal brain .r 514 to 1341 1 to 828   fully sequenced,   828/828
(100 %)
3 diff
(99.7 %id)
CF529634 placenta .r 523 to 980 476 to 19   AAA   458/458
(100 %)
2 diff
(99.6 %id)
AI859672 serous papillary carcinoma, high grade, 2pooled tumors, uterus .r 524 to 980 457 to 1       457/457
(100 %)
3 diff
(99.4 %id)
AV741643 cord Blood .r 582 to 990 1 to 397   AAA   397/397
(100 %)
11 diff
(97.3 %id)
AI872162 ovary, tumor, 5 pooled (see description) .r 594 to 981 390 to 3       388/390
(99 %)
0 diff
(100 %id)
AI225033 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .r 606 to 980 375 to 1       375/375
(100 %)
1 diff
(99.8 %id)
N25905 placenta .r 608 to 980 375 to 1       375/462
(81 %)
9 diff
(98.1 %id)
AI129891 uterus .r 608 to 993 410 to 25   AAA   386/386
(100 %)
10 diff
(97.5 %id)
AW674548 cervical carcinoma cell line, cervix .r 611 to 981 371 to 1   available from MGC,   371/371
(100 %)
3 diff
(99.2 %id)
AA522843 metastatic prostate bone lesion .r 626 to 980 388 to 34   AAA   355/356
(99 %)
2 diff
(99.5 %id)
AI709084 aorta .r 637 to 979 343 to 1       343/343
(100 %)
3 diff
(99.2 %id)
GD136245   .r 650 to 980 1 to 330   AAA   330/330
(100 %)
2 diff
(99.4 %id)
GD157740   .r 650 to 980 1 to 331   AAA   331/331
(100 %)
3 diff
(99.1 %id)
BE221692 malignant melanoma, metastatic to lymphnode, skin .r 672 to 980 310 to 1       310/314
(98 %)
8 diff
(97.5 %id)
AA908397 ovary, serous adenocarcinoma .r 673 to 983 310 to 1       310/310
(100 %)
2 diff
(99.4 %id)
AI915448 ovary, tumor, 5 pooled (see description) .r 754 to 980 254 to 28   AAA   227/227
(100 %)
3 diff
(98.7 %id)
BG996839 head_neck .r 808 to 955 1 to 146       146/146
(100 %)
3 diff
(98.0 %id)
BG984930 colon_normal .r 825 to 1041 1 to 217       217/217
(100 %)
4 diff
(98.2 %id)
CN366545 embryonic stem cells, DMSO-treated H9 cellline .r 1199 to 1655 1 to 457       457/457
(100 %)
1 diff
(99.8 %id)
TI_149314978   .r 1303 to 2237 1011 to 88   AAA   924/1019
(90 %)
18 diff
(98.3 %id)
AL536020 brain, fetal brain .r 1311 to 2216 906 to 1   fully sequenced,   906/906
(100 %)
32 diff
(96.5 %id)
BF756527 colon .r 1326 to 1468 16 to 157       142/157
(90 %)
6 diff
(96.2 %id)
BQ319207 colon .r 1339 to 1468 1 to 132       132/132
(100 %)
9 diff
(93.2 %id)
BM798023 Ascites, stomach .r 1421 to 1851 1 to 431       431/431
(100 %)
0 diff
(100 %id)
CN479181 lung, Primary Lung Cystic Fibrosis EpithelialCells .r 1559 to 2237 699 to 19   AAA   681/681
(100 %)
3 diff
(99.6 %id)
BI257549 cervical carcinoma cell line, cervix .r 1605 to 2239 1 to 645   AAA   645/660
(97 %)
21 diff
(96.9 %id)
H46276 brain .r 1784 to 2220 443 to 1       443/469
(94 %)
18 diff
(96.2 %id)
AF075052   .r 1787 to 2237 1 to 452   AAA   452/452
(100 %)
10 diff
(97.8 %id)
BX102072 brain .r 1789 to 2237 1 to 450   AAA   450/450
(100 %)
9 diff
(98.0 %id)
AA704185 liver and spleen .r 1791 to 2238 447 to 1       447/447
(100 %)
4 diff
(99.2 %id)
AW629400 pooled .r 1849 to 2238 390 to 1       390/390
(100 %)
0 diff
(100 %id)
BF894163 marrow .r 1926 to 2407 7 to 489       483/489
(98 %)
7 diff
(98.6 %id)
AW970811   .r 1940 to 2236 298 to 1     Submitted on the opposite strand 298/425
(70 %)
2 diff
(99.6 %id)
H19509 brain .r 1940 to 2238 304 to 1       304/317
(95 %)
12 diff
(96.3 %id)
AA705507 liver and spleen .r 1944 to 2238 295 to 1       295/295
(100 %)
0 diff
(100 %id)
AA563638 colon .r 1972 to 2239 271 to 4       268/271
(98 %)
0 diff
(100 %id)
BQ334417 marrow .r 1982 to 2424 483 to 37   tiling clone,   447/484
(92 %)
12 diff
(97.6 %id)
BQ334425 marrow .r 2044 to 2464 426 to 4   tiling clone,   423/428
(98 %)
0 diff
(100 %id)
CA307260 Alveolar Macrophage, lung .r 2106 to 2237 150 to 19   AAA   132/132
(100 %)
1 diff
(99.3 %id)
BI053056 placenta_normal .r 2183 to 2510 33 to 359   tiling clone,   327/359
(91 %)
6 diff
(98.4 %id)
AI082744 liver and spleen .r 2351 to 2879 529 to 2   tiling clone,   528/529
(99 %)
0 diff
(100 %id)
BX504913   .s 1 to 600 6 to 604   tiling clone,   604/604
(100 %)
3 diff
(99.6 %id)
DA033510   .s 45 to 605 2 to 562   capped   561/561
(100 %)
4 diff
(99.3 %id)
DA644099   .s 48 to 592 2 to 549   capped   548/548
(100 %)
5 diff
(99.1 %id)
DA482629   .s 49 to 621 2 to 574   tiling clone, capped   573/573
(100 %)
3 diff
(99.5 %id)
BX494184 Liver .s 50 to 577 1 to 529       529/529
(100 %)
2 diff
(99.7 %id)
BX951054   .s 51 to 528 1 to 479       479/479
(100 %)
1 diff
(99.8 %id)
DA654944   .s 51 to 619 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA959326 Spleen .s 52 to 597 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DB151234 thymus .s 52 to 609 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DB228462 trachea .s 52 to 615 2 to 564   capped   563/563
(100 %)
3 diff
(99.5 %id)
DB250479 uterus .s 52 to 516 2 to 467   capped   466/466
(100 %)
3 diff
(99.4 %id)
DA019774   .s 53 to 579 2 to 528   capped   527/527
(100 %)
1 diff
(99.9 %id)
DA656688   .s 53 to 530 2 to 481   capped   480/480
(100 %)
1 diff
(99.8 %id)
DA864394 placenta .s 53 to 482 2 to 433   capped   432/432
(100 %)
2 diff
(99.6 %id)
DB120218 thymus .s 53 to 615 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DB232238 trachea .s 53 to 642 2 to 590   capped   589/589
(100 %)
5 diff
(99.2 %id)
DB278219 uterus .s 53 to 541 2 to 491   capped   490/490
(100 %)
2 diff
(99.6 %id)
CN418810 embryonic stem cells, cell lines H1, H7, andH9 .s 60 to 214 1 to 154       154/154
(100 %)
7 diff
(95.5 %id)
AA299421 uterus .s 65 to 198 1 to 134       134/143
(93 %)
4 diff
(97.3 %id)
BX477113   .s 101 to 529 1 to 429       429/429
(100 %)
5 diff
(98.9 %id)
CN418811 embryonic stem cells, cell lines H1, H7, andH9 .s 125 to 519 1 to 395       395/395
(100 %)
1 diff
(99.8 %id)
AK092726   .s 359 to 2972 1 to 2612 W19R tiling clone, available from FLJ,   2612/2612
(100 %)
5 diff
(99.9 %id)
DA913568   .s 360 to 804 2 to 447 W19R H73X capped   446/446
(100 %)
3 diff
(99.4 %id)
BU951493 Pancreas, Purified pancreatic islet .s 375 to 844 1 to 470 R26I   Submitted on the opposite strand 470/470
(100 %)
2 diff
(99.6 %id)
BF892822 marrow .s 601 to 1093 25 to 516       492/524
(93 %)
8 diff
(98.5 %id)
CV402516 amnion_normal .s 738 to 988 250 to 1     Submitted on the opposite strand 250/429
(58 %)
1 diff
(99.8 %id)
CX783521 human embryonic stem cells .s 876 to 1631 1 to 756   tiling clone,   756/756
(100 %)
0 diff
(100 %id)
CN268033 embryonic stem cells, cell lines H1, H7, andH9 .s 1667 to 2314 1 to 647       647/647
(100 %)
1 diff
(99.9 %id)
CR608897 Neuroblastoma Cot 10-normalized .s 2124 to 2972 1 to 849       849/849
(100 %)
0 diff
(100 %id)
DB331458   .s 2430 to 2972 544 to 1       544/544
(100 %)
1 diff
(99.9 %id)
DB329135 placenta .s 2438 to 2972 535 to 1       535/535
(100 %)
0 diff
(100 %id)
DA055081 cerebellum .t 1 to 554 2 to 551 S18A tiling clone, capped   550/550
(100 %)
4 diff
(99.3 %id)
DA552155   .t 51 to 542 2 to 493   capped   492/492
(100 %)
3 diff
(99.4 %id)
DA837783 placenta .t 53 to 594 2 to 543   tiling clone, capped   542/542
(100 %)
0 diff
(100 %id)
DB010292 colon, tumor tissue .t 53 to 618 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DB194196 ovary, tumor tissue .t 53 to 594 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
NR_004404.1   .t 523 to 680 1 to 158   RefSeq, tiling clone,   158/158
(100 %)
0 diff
(100 %id)
NR_004406.1   .t 523 to 727 1 to 205   RefSeq, tiling clone,   205/205
(100 %)
5 diff
(97.6 %id)
DA381375 thalamus .t 729 to 1299 53 to 623   tiling clone, capped   571/628
(90 %)
4 diff
(99.4 %id)
DB296505 cerebellum .t 1039 to 1598 560 to 1   tiling clone,   560/560
(100 %)
2 diff
(99.7 %id)
DB156477 thymus .u-u 1 to 569 2 to 570 exact tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
BF908738 uterus_tumor .u-u 304 to 668 48 to 412 exact     365/412
(88 %)
6 diff
(98.6 %id)
L07382   .u-u 492 to 698 1 to 208       208/208
(100 %)
1 diff
(99.6 %id)
NR_002907.2   .u-u 492 to 698 1 to 207   RefSeq, tiling clone,   207/207
(100 %)
0 diff
(100 %id)
S63405   .u-u 492 to 698 1 to 208       208/208
(100 %)
2 diff
(99.1 %id)
AI652562 pooled germ cell tumors .va 1 to 475 478 to 4 P22X tiling clone,   475/478
(99 %)
0 diff
(100 %id)
BF094114 uterus_tumor .vb-u 1 to 266 384 to 118 L37R H38T S39L G40R S41V ... tiling clone,   267/384
(69 %)
0 diff
(100 %id)
DW443134 Liver .vc-u 1 to 214 18 to 232 K13T W15S R16E N17K T19H ... tiling clone,   215/232
(92 %)
6 diff
(97.5 %id)
AV705366 adrenal gland Gene SNHG3_, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
AK311577 testis Gene SNHG3_, variant not shown         Suspected internal deletion, this clone was ignored    
BF744034 breast Gene SNHG3_, variant not shown         This clone was ignored    
CN366542 embryonic stem cells, DMSO-treated H9 cellline Gene SNHG3_, variant not shown         Suspected internal deletion, this clone was ignored    
CR604404 Neuroblastoma Cot 25-normalized Gene SNHG3_, variant not shown         Suspected internal deletion, this clone was ignored    
AL523115 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized Gene SNHG3_, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
AL523116 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized Gene SNHG3_, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
DW417474 Liver Gene SNHG3_, variant not shown         Suspected internal deletion, this clone was ignored    
DW445041 Liver Gene SNHG3_, variant not shown         This clone was ignored    
AV689452 hepatocellular carcinoma Gene SNHG3_, variant not shown         Suspected internal deletion, this clone was ignored    
AA143406 Pancreas Gene SNHG3_, variant not shown         This clone was ignored    
AA146574 Pancreas Gene SNHG3_, variant not shown         This clone was ignored    
AW449599   Gene SNHG3_, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BQ947953 epidermoid carcinoma, cell line, lung Gene SNHG3_, variant not shown         Suspected internal deletion, this clone was ignored    
CB985055 Pooled-Glandular Gene SNHG3_, variant not shown         This clone was ignored    
CT004556 T-Lymphocytes Gene SNHG3_, variant not shown         This clone was ignored    
BM788818 Ascites, stomach Gene SNHG3_, variant not shown         This clone was ignored    
DB024065 testis Gene SNHG3_, variant not shown       capped Suspected internal deletion, this clone was ignored    
BU622671 cell lines, Chondrosarcoma Gene SNHG3_, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q-u, .r, .s, .t, .u-u, .va, .vb-u, .vc-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI